IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
0.613
-0.017 (-2.71%)
At close: Mar 9, 2026, 4:00 PM EDT
0.610
-0.003 (-0.47%)
After-hours: Mar 9, 2026, 4:01 PM EDT
IceCure Medical Revenue
IceCure Medical had revenue of $850.00K in the quarter ending September 30, 2025, with 28.40% growth. This brings the company's revenue in the last twelve months to $2.98M, down -18.96% year-over-year. In the year 2024, IceCure Medical had annual revenue of $3.29M with 1.92% growth.
Revenue (ttm)
$2.98M
Revenue Growth
-18.96%
P/S Ratio
14.60
Revenue / Employee
$45,076
Employees
66
Market Cap
43.27M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.29M | 62.00K | 1.92% |
| Dec 31, 2023 | 3.23M | 144.00K | 4.67% |
| Dec 31, 2022 | 3.09M | -1.05M | -25.45% |
| Dec 31, 2021 | 4.14M | 270.00K | 6.98% |
| Dec 31, 2020 | 3.87M | 2.21M | 132.76% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Outset Medical | 119.48M |
| TELA Bio | 77.06M |
| Myomo | 41.64M |
| Cytosorbents | 36.98M |
| electroCore | 29.84M |
| Spectral AI | 23.17M |
| Elutia | 21.75M |
ICCM News
- 8 hours ago - American Society of Breast Surgeons (ASBrS) Resource Guide Update Recommends Cryoablation for Low-Risk Breast Cancer - PRNewsWire
- 7 days ago - IceCure Medical Reports Independent Study Published in PLOS One Demonstrating ProSense® Cryoablation Safe and Effective in Treatment of Breast Fibroadenomas - PRNewsWire
- 14 days ago - IceCure Medical Successfully Completes 5-Year Patient Follow Up in ICESECRET Kidney Cancer Cryoablation Study: Final Analysis Expected in Second Quarter of 2026 - PRNewsWire
- 18 days ago - IceCure Announces Thomas Hospital of Infirmary Health Installs ProSense®, Becomes First Hospital in Alabama to Offer Breast Cancer Cryoablation - PRNewsWire
- 26 days ago - IceCure Announces Shero Imaging is First to Offer Breast Cancer Cryoablation Procedures in Missouri with ProSense® - PRNewsWire
- 27 days ago - IceCure Announces Planned Departure of CFO Following Nine Years of Service and Key Milestones Achieved - PRNewsWire
- 5 weeks ago - IceCure Celebrates American Society of Breast Surgeons' (ASBrS) Proposed Breast Cancer Treatment Guidelines Which Include Cryoablation for Low-Risk Breast Cancer - PRNewsWire
- 2 months ago - IceCure CEO Issues Letter to Shareholders: Reports Record Fourth Quarter and Full Year 2025 ProSense® Sales - PRNewsWire